Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 7, 2006, Pages 877-879

  Exley, C ^a   Esiri, M M ^b,c  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN; ALUMINUM POTASSIUM SULFATE; ALUMINUM SULFATE;

ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CEREBROVASCULAR DISEASE; DISEASE SEVERITY; EXPOSURE VARIABLE; GOVERNMENT; HEALTH CARE; HUMAN; INCIDENT REPORT; LAW; MEDICAL RESEARCH; NEUROPATHOLOGY; POPULATION EXPOSURE; PRIORITY JOURNAL; RESIDENT; UNITED KINGDOM; WATER CONTAMINATION; ACCIDENT; ADULT; BRAIN; BRAIN LEVEL; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; MIDDLE AGED; PATHOLOGY; VASCULAR AMYLOIDOSIS; WATER SUPPLY;

ACCIDENTS; ADULT; ALUM COMPOUNDS; ALUMINUM; ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; CEREBRAL AMYLOID ANGIOPATHY; ENGLAND; FEMALE; HUMANS; MIDDLE AGED; WATER SUPPLY;

EID: 33745316086     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.086553     Document Type: Article

References (15)

1. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
2. 4) is a significant influence upon the atomic absorption signal of aluminium measured by graphite furnace atomic absorption spectrometry (GFAAS). J Inorg Biochem 2001;87:45-50.
3. Andrási E, Páli N, Molnár Z, et al. Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. J Alzheimer's Dis 2005;7:273-84.
4. Reusche E, Pilz P, Oberascher G, et al. Subacute fatal aluminium encephalopathy after reconstructive otoneurosurgery: a case report. Hum Pathol 2001;32:1136-40.
5. Meshitsuka S, Koeda T, Hara T, et al. Abnormal aluminium metabolism in two siblings with progressive CNS calcification. Dev Med Child Neurol 2001;43:286-88.
6. Alfrey AC, LeGendre GR, Keahny WD. The dialysis encephalopathy syndrome - possible aluminum intoxication. N Engl J Med 1976;294:184-8.
7. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience. Neurology 1996;46:1592-6.
8. Plant GT, Ghiso J, Holton JL, et al. Familial and sporadic cerebral amyloid angiopathies associated with dementia and the BRI dementias. In: Esiri MM, Lee M-Y, Trojanowski JQ, eds. The neuropathology of dementia. 2nd edn. Cambridge: Cambridge University Press, 2004:330-52.
9. Yamada M, Itoh Y, Suematsu N, et al. Vascular variant of Alzheimer's disease characterized by severe plaque-like beta protein angiopathy. Dementia Geriatr Cogn Disord 1997;8:163-8.
10. Giasson BI, Lee V M-Y, Trojanowski JQ. Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and the spectrum of diseases with alpha synuclein inclusions. In: Esiri MM, Lee M-Y, Trojanowski JQ, eds. The neuropathology of dementia. 2nd edn. Cambridge: Cambridge University Press, 2004:353-7.
11. Yip AG, McKee AC, Green RC, et al. APOE, vascular pathology, and the AD brain. Neurology 2005;65:259-65.
12. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
13. Solomon B, Koppel R, Jossiphov J. Immunostaining of calmodulin and aluminium in Alzheimer's disease-affected brains. Brain Res Bull 2001;55:253-6.
14. Exley C, Price NC, Kelly SM, et al. An interaction of β-amyloid with aluminium in vitro. FEBS Lett 1993;324:293-5.
15. 42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J Alzheimer's Dis 2004;6:291-301.